Europe begins reviewing application for AstraZeneca COVID-19 drug - CNA

3/16/2022 12:00:00 AM3 years 11 months ago

Europe's drug regulator said on Tuesday (Mar 15) it had begun reviewing AstraZeneca Plc's application for antibody-based COVID-19 therapy, a key step towards approval of the treatment in the region, but gave no timeline for a conclusion. Infections from CO…

Europe's drug regulator said on Tuesday (Mar 15) it had begun reviewing AstraZeneca Plc's application for antibody-based COVID-19 therapy, a key step towards approval of the treatment in the region, … [+996 chars]

full article...